结核病与肺部健康杂志 ›› 2013, Vol. 2 ›› Issue (4): 263-269.doi: 10.3969/j.issn.2095-3755.2013.04.010

• 论著 • 上一篇    下一篇

播散性马尔尼菲青霉菌病误诊为结核病一例报道及文献复习

李德宪,谭守勇,谭耀驹,何桥   

  1. 510095 广州市胸科医院结核内科 呼吸疾病国家重点实验室(李德宪、谭守勇),检验科(谭耀驹),病理科(何桥)
  • 收稿日期:2013-11-24 出版日期:2013-11-30 发布日期:2013-11-30
  • 通信作者: 谭守勇,Email:tanshouyong@163.com
  • 基金资助:
    国家“十二五”重大科技专项(2012ZX100004903-001-002)

Disseminated Penicilliosis marneffei misdiagnosed as tuberculosis: a case report and literatures review

LI De-xian,TAN Shou-yong, TAN Yao-ju,HE Qiao   

  1. Guangzhou Chest Hospital,State Key Laboratory of Respiratory Disease,Guangzhou 510095,China
  • Received:2013-11-24 Online:2013-11-30 Published:2013-11-30
  • Contact: TAN Shou-yong,Email:tanshouyong@163.com

摘要: 目的 提高对播散性马尔尼菲青霉菌病(PSM)与结核病鉴别诊断的认识。方法 对2007年11月入住广州市胸科医院的1例早期病理诊断为结核病、抗结核治疗失败、最终诊断为播散性PSM患者的临床特点、影像学、病原学、病理学及诊疗过程进行回顾,并对PSM进行文献复习。结果 患者男性,60岁,广东人。以咳嗽、发热、消瘦、多发淋巴结肿大、多发皮下脓肿、进行性呼吸窘迫为临床表现,胸部影像学提示:双肺浸润阴影、纵隔淋巴结肿大、双侧胸腔积液、心包积液;实验室检查显示:白细胞进行性升高达45.23×109/L,CD4+ T淋巴细胞计数353个/μl,CD4/CD8为1.19,HIV抗体阴性;胸腔积液病原学培养阴性;并曾2次病理诊断拟诊为淋巴结结核;抗结核治疗无效。血液、胸腔积液、脓液标本均培养出马尔尼菲青霉菌,再次淋巴结活检确诊为播散性PSM。停止抗结核治疗及停用糖皮质激素,并加用伏立康唑抗真菌治疗,但最终仍因呼吸、循环衰竭,经抢救无效死亡。结论 PSM延误治疗者预后较差,其早期临床表现、影像学特征与病理所见易与结核病混淆。对于抗结核治疗无效,又在PSM流行区居住的患者,即使没有宿主因素,也需注意患本病的可能,应及早行多部位取材做相关病原学检测,特别是真菌的双相培养,以便及时诊断和治疗。

Abstract: Objective To improve the knowledge of disseminated Penicilliosis marneffei as to help differential diagnosis this disease from tuberculosis in immunocompetent patient. Methods The clinical, chest imaging, bacteriological and pathological characteristics and the diagnostic and therapeutic course from one patient with immunocompetent patient who was admitted to Guangzhou Chest Hospital in November 2007, misdiagnosed initially as tuberculosis and then confirmed as Penicilliosis marneffei, were analyzed retrospectively. Meanwhile the literatures on Pecicilliosis marneffei were reviewed. Results A 60-year-old cantonese male without HIV infection was presented as cough, fever, weight loss, enlargement of multiple lymph nodes, multiple subcutaneous abscesses and rapidly progressive respiratory failure. Chest imaging showed bilateral pulmonary infiltrates, enlargement of mediastinal lymph nodes, bilateral pleural effusion and pericardial effusion. The laboratory examination showed white cell counts increased rapidly up to 45.23×109/L in the peripheral blood,353 cells/μl in CD4+ T-lymphocyte count, 1.19 in CD4/CD8 ratio and HIV seronegative. The early culture from the pleural effusion was negative. The patient, who was early diagnosed as TB by pathology twice and failed to response to antituberculosis therapy, was finally proved as a disseminated Penicilliosis marneffei by the fungus positive in clinical specimens from blood, pleural effusion and purulent exudates by microscopy and culture. And the lymph node biopsy was performed again to prove the disease, with microscopic demonstration of intracellular Penicillium marneffei yeast cells in the infected tissue. The antituberculosis therapy and corticosteroid treatment were discontinued, and the antifungal therapy with voriconazole was implemented. The patient developed subsequently respiratory and circulatory failure, and died after 4 days with voriconazole administration. Conclusion Patients with Penicilliosis marneffei have a poor prognosis without the appropriate antifungal treatment.The early clinical features, imaging findings and pathological characteristics of the disease were easily confused with those of TB. Patient from areas where the infection is endemic, Penicillium marneffei infection should be suspected when the patient failed to response to antituberculosis therapy even if immunocompetence. Early identified the fungus in clinical specimens from purulent exudates by culture at different temperatures (25 ℃ and 37 ℃) should be considered.